» Articles » PMID: 34746993

Effects of Ovarian Endometrioma Aspiration on in Vitro Fertilization-intracytoplasmic Sperm Injection and Embryo Transfer Outcomes: a Systematic Review and Meta-analysis

Overview
Date 2021 Nov 8
PMID 34746993
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the effect of ovarian endometrioma aspiration on IVF/ICSI outcomes.

Methods: The PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure, and Wanfang databases were searched to identify studies related to the treatment of endometrioma up to October 1, 2020, and the data of 1207 patients from 10 studies were analyzed using STATA.

Results: The 10 studies in our analysis included 7 comparing aspiration and surgery and 6 comparing aspiration with no intervention. In the aspiration versus surgery groups, live birth rate [OR 0.97 (95% CI 0.51, 1.85), P = 0.925] and clinical pregnancy rate [OR 1.30 (95% CI 0.95, 1.80), P = 0.105] showed no significant difference between the two groups. Abortion rate [OR 4.26 (95% CI 1.38, 13.08), P = 0.011], the number of oocytes retrieved [mean difference 1.95 (95% CI 0.10, 3.81), P = 0.039], and the estradiol peak on hCG day [mean difference 392.16 (95% CI 230.14, 554.18), P < 0.001] were significantly higher in the aspiration group compared to the surgical group. In the aspiration versus the no intervention group, live birth rate [OR 0.84 (95% CI 0.45, 1.59), P = 0.602] and clinical pregnancy rate [OR 1.25 (95% CI 0.88, 1.77), P = 0.206] were not significantly different between the two groups. The abortion rate [OR 0.31 (95% CI 0.11, 0.88), P = 0.028] and the number of gonadotropin ampoules [mean difference - 3.13 ampoules (95% CI - 4.90, - 1.37), P < 0.001] were significantly lower in the aspiration group compared to the no intervention group.

Conclusion: Compared with surgical treatment or no intervention treatment, aspiration has less effect on ovarian response, ovarian reserve, and pregnancy outcomes.

Citing Articles

Assisted Reproductive Technology Outcomes After Ethanol Sclerotherapy in Poor Responder Patients with Endometriomas: A Before-After Clinical Trial.

Ghasemi F, Kashani L, Moini A, Farid Mojtahedi M, Shahhosseini R, Alemohammad F J Reprod Infertil. 2025; 25(3):224-230.

PMID: 39830317 PMC: 11736268. DOI: 10.18502/jri.v25i3.17017.


The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews.

Younis J, Taylor H Front Endocrinol (Lausanne). 2024; 15:1397279.

PMID: 38800489 PMC: 11116636. DOI: 10.3389/fendo.2024.1397279.


Exploring the Impact of Endometrioma Aspiration and Dienogest Combination Therapy on Cyst Size, Inflammatory Cytokines in Follicular Fluid and Fertility Outcomes.

Shigeta M, Tsuji I, Hashimoto S, Kankanam Gamage U, Yamanaka M, Fukuda A Int J Mol Sci. 2023; 24(16).

PMID: 37629072 PMC: 10454828. DOI: 10.3390/ijms241612891.


A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis.

Wang M, Zheng L, Lin R, Ma S, Li J, Yang S Front Endocrinol (Lausanne). 2023; 14:1199569.

PMID: 37455911 PMC: 10338222. DOI: 10.3389/fendo.2023.1199569.


Letter to the editor regarding: "The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis".

Harborg S, Ahern T, Borgquist S Arch Gynecol Obstet. 2021; 306(2):567-568.

PMID: 34694433 DOI: 10.1007/s00404-021-06307-0.

References
1.
Alborzi S, Zahiri Sorouri Z, Askari E, Poordast T, Chamanara K . The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019; 18(4):312-322. PMC: 6780037. DOI: 10.1002/rmb2.12286. View

2.
Kuivasaari P, Hippelainen M, Anttila M, Heinonen S . Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod. 2005; 20(11):3130-5. DOI: 10.1093/humrep/dei176. View

3.
Jenkins S, Olive D, Haney A . Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol. 1986; 67(3):335-8. View

4.
Redwine D . Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999; 72(2):310-5. DOI: 10.1016/s0015-0282(99)00211-3. View

5.
Gupta S, Agarwal A, Agarwal R, Loret de Mola J . Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online. 2006; 13(3):349-60. DOI: 10.1016/s1472-6483(10)61439-3. View